ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
Vivo Bio Tech has sent letters to shareholders without registered email addresses, providing a web-link to access the Annual Report for the financial year 2025-26.
Vivo Bio Tech Ltd filed its routine quarterly shareholding pattern for the period ending June 30, 2026.
Vivo Bio Tech Limited submitted its Annual Secretarial Compliance Report for the financial year 2026. This filing fulfills regulatory disclosure requirements under SEBI (LODR) Regulations.
Vivo Bio Tech Limited reported zero requests for the re-lodgement of physical share transfers for the period ended March 2026. This routine SEBI compliance filing, received from the company's Registrar and Share Transfer Agent, Aarthi Consultants Private Limited, confirms no activity in this category during the month.
Vivo Bio Tech Limited submitted its quarterly compliance certificate under Regulation 74(5) of SEBI Regulations for the period ended March 31, 2026. The certificate confirms that security certificates received for dematerialisation were processed and cancelled by their Registrar, Aarthi Consultants Private Limited.